The University of Chicago Medicine's Brain Tumor Center is at the forefront of sophisticated care for tumors of the central nervous system (CNS), the part of the nervous system that consists of the brain and spinal cord.

Our multidisciplinary team — neuro-oncologists, neurosurgeons, radiation oncologists and hematologist/oncologists — work together to plan and deliver individualized patient care for brain and spinal cord tumors, including:

  • Definitive diagnostic assessments using the latest technology and minimally invasive techniques to pinpoint even the most difficult-to-detect tumors
  • A range of comprehensive treatment options for non-malignant and malignant brain and spinal cord tumors
  • Management of cancer that has spread to the brain or spinal cord, also known as metastatic brain tumors, is led by experts in our CNS metastases clinic.
  • Specialized expertise in hemangioblastomas of the brain and spine associated with von Hippel-Lindau disease

Leading the Advancement of Brain & Spinal Cord Tumor Treatment

At our Brain Tumor Center, treatment strategies are guided by innovative research conducted at UChicago Medicine. Our scientists are dedicated to building a foundation for future advancements in the treatment of brain and spinal cord tumors.

Through our basic research program, scientists are investigating the underlying mechanisms involved in how brain and spinal cord tumors develop, survive and spread. Through collaborative initiatives with the UChicago Medicine Comprehensive Cancer Center, our experts are poised to substantially advance the treatment and prevention of brain and spinal cord metastases. Such basic and translational science endeavors are supported by numerous grants, including the $90 million grant supporting the Ludwig Center for Metastases Research.

Access to Innovative Clinical Trials

UChicago Medicine experts are also conducting robust clinical research focused on brain and spinal cord tumors. Our Comprehensive Cancer Center offers access to the entire range of Phase I, II, and III clinical trials supported by the National Institutes of Health (NIH) for newly-diagnosed and progressive gliomas, as well as brain metastases.

In addition to national trials supported by the NIH, we also conduct industry- and investigator-sponsored clinical trials. These studies involve a range of treatments including surgery, radiation, chemotherapy, targeted drugs, immunotherapy and vaccines.

Convenient Locations for Cancer Care